The sabin vaccine institute initiated a phase 2 clinical trial of its marburg vaccine candidate in the united states, marking an important step towards developing a preventative measure for this deadly … A phase 2 clinical trial for sabin’s marburg vaccine candidate is currently underway in uganda and kenya, and the united states. The objective of the trial is to evaluate the vaccine’s safety and …

One treatment center hcw vaccinated on oct 9 was later confirmed marburg positive*. The sabin vaccine institute has launched a multi-site phase 2 clinical trial in the united states for its marburg virus vaccine candidate, administering initial doses to participants in melbourne, florida.